ScheBo Biotech, a global leader in the provision of unique diagnostic tests, has made some significant improvements to its Pancreatic Elastase 1 Serum Test for acute pancreatitis. The modifications are similar to those made last year to the ScheBo Pancreatic Elastase 1 Stool Test (also known as the Faecal Elastase Test), which is now generally accepted as the non-invasive ætest of choiceÆ for measuring pancreatic exocrine function.
Other News
Latest Issues
Benson Viscometers is a world-leading manufacturer of clinical viscometers, trusted by hospitals, laboratories, universities and research institutions across the UK, USA, and Europe. Since 1999, they have provided reliable, high-precision clinical viscosity testing to support improved patient outcomes in conditions such as Multiple Myeloma,...
London GI Pathology Update 2026
Barbican Centre, London; and online.
28 April - 1 May
Specialist Staining – Technical Issues Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
28 April, 2026
Diagnostic Cytopathology – Beginners Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 May, 2026
Power to Disrupt : Leaders in POCT Diagnostics
Leonardo Royal Hotel, 245 Broad St, Birmingham, B1 2HQ
5 May, 2026
Diagnostic Cytopathology – Intermediate Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
6 May, 2026